Kaiser Permanente Ventures and Cigna Ventures participated in a $34 million funding round for NOCD, a company that offers virtual treatment for obsessive-compulsive disorder.
Kaiser Permanente Ventures and Cigna Ventures participated in a $34 million funding round for NOCD, a company that offers virtual treatment for obsessive-compulsive disorder.
Copyright © 2024 | WordPress Theme by MH Themes